| Marsha Hillary Onan, MD | |
|
11111 Research Blvd, Suite 220, Austin, TX 78759-5264 | |
| (512) 324-6755 | |
| (512) 324-6753 |
| Full Name | Marsha Hillary Onan |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Location | 11111 Research Blvd, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376545186 | NPI | - | NPPES |
| 117115905 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | K3623 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marsha Hillary Onan, MD 1600 W 38th St, Suite 320, Austin, TX 78731-6400 Ph: (512) 324-3310 | Marsha Hillary Onan, MD 11111 Research Blvd, Suite 220, Austin, TX 78759-5264 Ph: (512) 324-6755 |
News Archive
Working with human brain tissue samples and genetically engineered mice, Johns Hopkins Medicine researchers together with colleagues at the National Institutes of Health, the University of California San Diego Shiley-Marcos Alzheimer's Disease Research Center, Columbia University, and the Institute for Basic Research in Staten Island say that consequences of low levels of the protein NPTX2 in the brains of people with Alzheimer's disease (AD) may change the pattern of neural activity in ways that lead to the learning and memory loss that are hallmarks of the disease.
Researchers from Isis Pharmaceuticals (Carlsbad, CA) and Prysis Biotechnologies (Pudong, Shanghai, China) have demonstrated proof-of-concept for using a sense oligonucleotide to undo the effects of an antisense drug, an antithrombotic agent in this novel study.
Disease progression-free survival is similar for patients with non-small-cell lung cancer and epidermal growth factor receptor mutations whether they receive erlotinib or gefitinib, show the results of a South Korean study.
With medical visits picking up again among patients vaccinated against Covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments.
Baxter International Inc. commends the Centers for Medicare and Medicaid Services (CMS) on announcing implementation plans for a new Medicare benefit that will provide Stage 4 chronic kidney disease patients with coverage for up to six sessions explaining their treatment options, such as transplantation, home peritoneal dialysis (PD), home hemodialysis (HHD) or clinic-based hemodialysis (HD).
› Verified 6 days ago
Dr. Kristen Michelle Hawthorne, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Saradha Chexal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy Ste 460, Austin, TX 78705 Phone: 512-454-5851 | |
Dr. John David Fisher, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2901 Montopolis Dr, Austin, TX 78741 Phone: 512-389-6571 Fax: 512-389-6511 | |
Dr. Clio Armitage Harper Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W 38th St, Suite 200, Austin, TX 78705 Phone: 512-451-0103 Fax: 512-451-2741 | |
Dr. Nadja Ivette Torres, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Fuad Makkouk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9707 Anderson Mill Rd Ste 230, Austin, TX 78750 Phone: 512-693-9363 | |
Irina Volosko, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3410 Far West Blvd Ste 140, Austin, TX 78731 Phone: 512-427-1107 Fax: 512-427-1207 |